Page last updated: 2024-09-05

sb 203580 and rutecarpine

sb 203580 has been researched along with rutecarpine in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(rutecarpine)
Trials
(rutecarpine)
Recent Studies (post-2010) (rutecarpine)
3,48941,1372351125

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)rutecarpine (IC50)
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)1.23
Cytochrome P450 1A1Homo sapiens (human)0.26
Cytochrome P450 1A2Homo sapiens (human)0.022
Prostaglandin G/H synthase 1Homo sapiens (human)8.7
Prostaglandin G/H synthase 2Homo sapiens (human)0.29
Cytochrome P450 1B1Homo sapiens (human)0.055

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bhavan, PS; Chung, CL; Hou, SM; Hsia, CH; Hsia, CW; Huang, WC; Jayakumar, T; Sheu, JR; Wu, MP1

Other Studies

1 other study(ies) available for sb 203580 and rutecarpine

ArticleYear
Decreased Human Platelet Activation and Mouse Pulmonary Thrombosis by Rutaecarpine and Comparison of the Relative Effectiveness with BAY11-7082: Crucial Signals of p38-NF-κB.
    Molecules (Basel, Switzerland), 2022, Jan-12, Volume: 27, Issue:2

    Topics: Animals; Disease Models, Animal; Fibrinolytic Agents; Free Radical Scavengers; Free Radicals; Humans; I-kappa B Kinase; Imidazoles; Indole Alkaloids; Male; Mice, Inbred ICR; NF-kappa B; Nitriles; P-Selectin; p38 Mitogen-Activated Protein Kinases; Platelet Activation; Protein Kinase Inhibitors; Pulmonary Embolism; Pyridines; Quinazolines; Sulfones; Thrombosis; Transcription Factor RelA

2022